PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
PLTK vs. EBS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

PLTK vs. EBS

Last updated May 13, 2025

Compare and contrast key facts about Playtika Holding Corp. (PLTK) and Emergent BioSolutions Inc. (EBS).

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PLTK or EBS.

Correlation

The correlation between PLTK and EBS is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

PLTK vs. EBS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Playtika Holding Corp. (PLTK) and Emergent BioSolutions Inc. (EBS). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

PLTK:

-0.77

EBS:

0.28

Sortino Ratio

PLTK:

-0.66

EBS:

1.33

Omega Ratio

PLTK:

0.91

EBS:

1.18

Calmar Ratio

PLTK:

-0.31

EBS:

0.33

Martin Ratio

PLTK:

-1.19

EBS:

0.77

Ulcer Index

PLTK:

23.11%

EBS:

41.94%

Daily Std Dev

PLTK:

45.00%

EBS:

125.12%

Max Drawdown

PLTK:

-87.38%

EBS:

-98.89%

Current Drawdown

PLTK:

-83.35%

EBS:

-95.67%

Fundamentals

Market Cap

PLTK:

$1.98B

EBS:

$316.98M

EPS

PLTK:

$0.38

EBS:

-$3.60

PS Ratio

PLTK:

0.76

EBS:

0.30

PB Ratio

PLTK:

0.00

EBS:

0.53

Total Revenue (TTM)

PLTK:

$2.60B

EBS:

$737.80M

Gross Profit (TTM)

PLTK:

$1.89B

EBS:

$181.00M

EBITDA (TTM)

PLTK:

$513.60M

EBS:

-$26.50M

Returns By Period

In the year-to-date period, PLTK achieves a -22.03% return, which is significantly higher than EBS's -38.91% return.

PLTK

YTD

-22.03%

1M

6.44%

6M

-34.72%

1Y

-34.42%

5Y*

N/A

10Y*

N/A

EBS

YTD

-38.91%

1M

33.03%

6M

-51.21%

1Y

34.25%

5Y*

-41.04%

10Y*

-14.34%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Risk-Adjusted Performance

PLTK vs. EBS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
PLTK
The Risk-Adjusted Performance Rank of PLTK is 1919
Overall Rank
The Sharpe Ratio Rank of PLTK is 1010
Sharpe Ratio Rank
The Sortino Ratio Rank of PLTK is 1818
Sortino Ratio Rank
The Omega Ratio Rank of PLTK is 1818
Omega Ratio Rank
The Calmar Ratio Rank of PLTK is 3030
Calmar Ratio Rank
The Martin Ratio Rank of PLTK is 1717
Martin Ratio Rank
EBS
The Risk-Adjusted Performance Rank of EBS is 6767
Overall Rank
The Sharpe Ratio Rank of EBS is 6262
Sharpe Ratio Rank
The Sortino Ratio Rank of EBS is 7373
Sortino Ratio Rank
The Omega Ratio Rank of EBS is 7373
Omega Ratio Rank
The Calmar Ratio Rank of EBS is 6666
Calmar Ratio Rank
The Martin Ratio Rank of EBS is 6060
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PLTK vs. EBS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Playtika Holding Corp. (PLTK) and Emergent BioSolutions Inc. (EBS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current PLTK Sharpe Ratio is -0.77, which is lower than the EBS Sharpe Ratio of 0.28. The chart below compares the historical Sharpe Ratios of PLTK and EBS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Loading data...

Dividends

PLTK vs. EBS - Dividend Comparison

PLTK's dividend yield for the trailing twelve months is around 7.56%, while EBS has not paid dividends to shareholders.

TTM202420232022202120202019201820172016
PLTK
Playtika Holding Corp.		7.56%5.76%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBS
Emergent BioSolutions Inc.		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%5.65%

Drawdowns

PLTK vs. EBS - Drawdown Comparison

The maximum PLTK drawdown since its inception was -87.38%, smaller than the maximum EBS drawdown of -98.89%. Use the drawdown chart below to compare losses from any high point for PLTK and EBS. For additional features, visit the drawdowns tool.

Loading data...

Volatility

PLTK vs. EBS - Volatility Comparison

The current volatility for Playtika Holding Corp. (PLTK) is 12.72%, while Emergent BioSolutions Inc. (EBS) has a volatility of 35.82%. This indicates that PLTK experiences smaller price fluctuations and is considered to be less risky than EBS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading data...

Financials

PLTK vs. EBS - Financials Comparison

This section allows you to compare key financial metrics between Playtika Holding Corp. and Emergent BioSolutions Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

200.00M300.00M400.00M500.00M600.00M700.00M20212022202320242025
706.00M
189.30M
(PLTK) Total Revenue
(EBS) Total Revenue
Values in USD except per share items

PLTK vs. EBS - Profitability Comparison

The chart below illustrates the profitability comparison between Playtika Holding Corp. and Emergent BioSolutions Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.
Gross Margin
Operating Margin
Net Margin
Quarterly
Annual
-20.0%0.0%20.0%40.0%60.0%80.0%20212022202320242025
72.0%
37.7%
(PLTK) Gross Margin
(EBS) Gross Margin
PLTK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Playtika Holding Corp. reported a gross profit of 508.60M and revenue of 706.00M. Therefore, the gross margin over that period was 72.0%.

EBS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Emergent BioSolutions Inc. reported a gross profit of 71.30M and revenue of 189.30M. Therefore, the gross margin over that period was 37.7%.

PLTK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Playtika Holding Corp. reported an operating income of 67.80M and revenue of 706.00M, resulting in an operating margin of 9.6%.

EBS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Emergent BioSolutions Inc. reported an operating income of -9.50M and revenue of 189.30M, resulting in an operating margin of -5.0%.

PLTK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Playtika Holding Corp. reported a net income of 30.60M and revenue of 706.00M, resulting in a net margin of 4.3%.

EBS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Emergent BioSolutions Inc. reported a net income of -31.30M and revenue of 189.30M, resulting in a net margin of -16.5%.